Tysabri

Tysabri (natalizumab) is an intravenous infusion used to treat relapsing forms of multiple sclerosis and moderate to severe Crohn's disease. This biologic therapy helps reduce flare-ups and maintain disease control. Seek medical advice for suitability and administration.

Tysabri is prescribed for relapsing forms of multiple sclerosis (MS) to slow disease progression and reduce flare-ups. It is also used for moderate to severe Crohn’s disease when other treatments have not been effective. Patients often ask, 'What is Tysabri used for?' to understand its role in managing these conditions.

Tysabri works by targeting specific immune cells to reduce inflammation in the central nervous system and digestive tract. Many patients report fewer symptoms and improved quality of life over time. Effects may vary, and regular monitoring is typically required during treatment.

Tysabri requires administration in a healthcare setting due to the risk of serious side effects. Patients should disclose their full medical history, including infections or immune disorders, before starting treatment. Regular blood tests and MRI scans may be recommended to monitor safety.

Tysabri may interact with immunosuppressants, corticosteroids, or other biologics, increasing infection risk. Combining it with certain medications could affect immune response. Alcohol use should be discussed with a healthcare provider, as it may influence treatment tolerance.